Rare diseases
Investigational molecules
Locations
Back to Austria39 clinical trials in Krems An Der Donau, Austria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
AustriaAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
AustriaA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
AustriaComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
AustriaA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
AustriaStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
AustriaStudy Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients
AustriaStudy on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on multiple myeloma treatments, including studies of novel drug combinations and maintenance therapies following stem cell transplantation. These trials aim to improve patient outcomes through targeted therapeutic approaches.
Innovative treatment combinations involving drugs like teclistamab, lenalidomide, and elranatamab are being evaluated.
Clinical investigations centered on pulmonary fibrosis and related conditions, exploring new therapeutic options for patients with progressive lung diseases.
Studies focus on improving lung function and reducing disease progression through novel therapeutic agents.
Advanced research in treating various types of solid cancers, with particular emphasis on prostate cancer, breast cancer, and lung cancer.
Trials evaluating targeted therapies and immunotherapy combinations for better treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
